Open Access. Powered by Scholars. Published by Universities.®
- Institution
Articles 1 - 2 of 2
Full-Text Articles in Engineering
Evaluation Of A Bisphosphonate Enriched Ultra-High Molecular Weight Polyethylene For Enhanced Total Joint Replacement Bearing Surface Functionality, Cassandra Wright-Walker
Evaluation Of A Bisphosphonate Enriched Ultra-High Molecular Weight Polyethylene For Enhanced Total Joint Replacement Bearing Surface Functionality, Cassandra Wright-Walker
All Dissertations
Each year in the United States there is an increasing trend of patients receiving total joint replacement (TJR) procedures. Approximately a half million total knee replacements (TKRs) are performed annually in the United States with increasing prevalence attributed to baby-boomers, obesity, older, and younger patients. This trend is also seen for total hip replacements (THRs) as well. The use of ultra high molecular weight polyethylene (UHMWPE) inserts in TJRs results in wear particle-induced osteolysis, which is the predominant cause for prosthesis failure and revision surgery. Sub-micron size particle generation is inevitable despite the numerous efforts in improving this bearing material. …
Bifunctional Bisphosphonates For Delivering Biomolecules To Bone, Jivan N. Yewle
Bifunctional Bisphosphonates For Delivering Biomolecules To Bone, Jivan N. Yewle
Theses and Dissertations--Chemistry
Active targeting with controlled delivery of therapeutic agents to bone is an ideal approach for treatment of several bone diseases. Since bisphosphonates (BPs) are known to have high affinity to bone mineral and are being widely used in treatment of osteoporosis, they are well-suited for drug targeting to bone. For this purpose, bifunctional hydrazine-bisphosphonates (HBPs) with spacers of various lengths and lipophilicity were synthesized and studied. Crystal growth inhibition assays demonstrated that the HBPs with shorter spacers bound more strongly to bone mineral, hydroxyapatite (HA), than did alendronate. HBPs were also demonstrated to be non-toxic to MC3T3-E1 pre-osteoblasts. The targeted …